Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy.
Luiz MT, Dutra JAP, Tofani LB, de Araújo JTC, Di Filippo LD, Marchetti JM, Chorilli M. Luiz MT, et al. Among authors: di filippo ld. Pharmaceutics. 2022 Apr 8;14(4):821. doi: 10.3390/pharmaceutics14040821. Pharmaceutics. 2022. PMID: 35456655 Free PMC article. Review.
Pharmaceutical nanotechnology: Antimicrobial peptides as potential new drugs against WHO list of critical, high, and medium priority bacteria.
Roque-Borda CA, Bento da Silva P, Rodrigues MC, Di Filippo LD, Duarte JL, Chorilli M, Vicente EF, Garrido SS, Rogério Pavan F. Roque-Borda CA, et al. Among authors: di filippo ld. Eur J Med Chem. 2022 Nov 5;241:114640. doi: 10.1016/j.ejmech.2022.114640. Epub 2022 Aug 9. Eur J Med Chem. 2022. PMID: 35970075 Review.
Current applications of drug delivery nanosystems associated with antimicrobial photodynamic therapy for oral infections.
Silvestre ALP, Di Filippo LD, Besegato JF, de Annunzio SR, Almeida Furquim de Camargo B, de Melo PBG, Rastelli ANS, Fontana CR, Chorilli M. Silvestre ALP, et al. Among authors: di filippo ld. Int J Pharm. 2021 Jan 5;592:120078. doi: 10.1016/j.ijpharm.2020.120078. Epub 2020 Nov 12. Int J Pharm. 2021. PMID: 33189809 Free article. Review.
Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression.
Di Filippo LD, Lobato Duarte J, Hofstätter Azambuja J, Isler Mancuso R, Tavares Luiz M, Hugo Sousa Araújo V, Delbone Figueiredo I, Barretto-de-Souza L, Miguel Sábio R, Sasso-Cerri E, Martins Baviera A, Crestani CC, Teresinha Ollala Saad S, Chorilli M. Di Filippo LD, et al. Int J Pharm. 2022 Apr 25;618:121682. doi: 10.1016/j.ijpharm.2022.121682. Epub 2022 Mar 17. Int J Pharm. 2022. PMID: 35307470
27 results